News about Mo Khan
SMALL CAP IDEAS: Hvivo aids major pharmaceutical firms in the 'tripledemic'
www.dailymail.co.uk,
December 12, 2022
Hvivo, formerly known as Open Orphanage, is at the forefront of the latest breakthroughs, not as a vaccine manufacturer but rather as a RSV specialist assisting drug developers in determining the effectiveness of their RSV treatments. It does this by organising human challenge studies at a medical center in Whitechapel, east London, where its scientists are able to monitor the effects of vaccine candidates on healthy volunteers.